{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:26:04Z","timestamp":1761017164154,"version":"3.41.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","primarycare.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.pop.2016.04.011","type":"journal-article","created":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T06:16:15Z","timestamp":1471500975000},"page":"433-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Allergic Dermatoses"],"prefix":"10.1016","volume":"43","author":[{"given":"Van","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ecler","family":"Jaqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2005","series-title":"Fitzpatrick's color atlas and synopsis of clinical dermatology","author":"Wolff","key":"10.1016\/j.pop.2016.04.011_bib1"},{"issue":"7","key":"10.1016\/j.pop.2016.04.011_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009864.pub2","article-title":"Topical tacrolimus for atopic dermatitis","author":"Cury Martins","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.pop.2016.04.011_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005205.pub3","article-title":"Dietary supplements for established atopic eczema","author":"Bath-Hextall","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.pop.2016.04.011_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jid.2010.251","article-title":"Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health","volume":"131","author":"Shaw","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"issue":"9352","key":"10.1016\/j.pop.2016.04.011_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","article-title":"Atopic dermatitis","volume":"361","author":"Leung","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.pop.2016.04.011_bib6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1365-2133.2002.04964.x","article-title":"The cost of atopic dermatitis in the Netherlands: an international comparison","volume":"147","author":"Verboom","year":"2002","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.pop.2016.04.011_bib7","first-page":"35","article-title":"Atopic dermatitis: an overview","volume":"86","author":"Berke","year":"2012","journal-title":"Am Fam Physician"},{"issue":"9117","key":"10.1016\/j.pop.2016.04.011_bib8","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(97)12082-7","article-title":"Atopic dermatitis","volume":"351","author":"Rudikoff","year":"1998","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.pop.2016.04.011_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1542\/pir.15-8-327","article-title":"Atopic dermatitis","volume":"15","author":"Lapidus","year":"1997","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.pop.2016.04.011_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jaci.2004.04.027","article-title":"How atopic is atopic dermatitis?","volume":"114","author":"Flohr","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl","key":"10.1016\/j.pop.2016.04.011_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifin","year":"1980","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.pop.2016.04.011_bib12","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMcp042803","article-title":"Atopic dermatitis","volume":"352","author":"Williams","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2016.04.011_bib13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.pop.2016.04.011_bib14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000096915","article-title":"The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study","volume":"214","author":"Grimalt","year":"2007","journal-title":"Dermatology"},{"year":"2007","series-title":"Atopic eczema in children: management of atopic eczema in children from birth up to the age of 12 years","key":"10.1016\/j.pop.2016.04.011_bib15"},{"issue":"3","key":"10.1016\/j.pop.2016.04.011_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaad.2003.08.003","article-title":"Guidelines of care of atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)\/American Academy of Dermatology Association \u201cAdministrative Regulations for Evidence-Based Clinical Practice Guide-lines\u201d","volume":"50","author":"Hanifin","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pop.2016.04.011_bib17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/bmj.310.6983.843","article-title":"Management of atopic eczema: Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London","volume":"310","author":"McHenry","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.pop.2016.04.011_bib18","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/bmj.324.7340.768","article-title":"Randomized controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema","volume":"324","author":"Thomas","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.pop.2016.04.011_bib19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2133.2002.05006.x","article-title":"Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients","volume":"147","author":"Hanifin","year":"2002","journal-title":"Br J Dermatol"},{"issue":"7403","key":"10.1016\/j.pop.2016.04.011_bib20","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1136\/bmj.326.7403.1367","article-title":"Multinational Study Group. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomized, double blind, parallel group study","volume":"326","author":"Berth-Jones","year":"2003","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.pop.2016.04.011_bib21","first-page":"739","article-title":"Topical use of pimecrolimus in atopic dermatitis: update on the safety and efficacy","volume":"7","author":"Werfel","year":"2009","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.pop.2016.04.011_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/09546630410033781","article-title":"Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis","volume":"15","author":"Luger","year":"2004","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"5","key":"10.1016\/j.pop.2016.04.011_bib23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jaad.2006.01.054","article-title":"The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force","volume":"54","author":"Berger","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"year":"2005","series-title":"Alert for healthcare professionals: pimecrolimus (marketed as Elidel)","author":"Center for Drug Evaluation and Research","key":"10.1016\/j.pop.2016.04.011_bib24"},{"year":"2005","series-title":"Alert for healthcare professionals: tacrolimus (marketed as Protopic)","author":"Idem","key":"10.1016\/j.pop.2016.04.011_bib25"},{"issue":"8","key":"10.1016\/j.pop.2016.04.011_bib26","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archderm.136.8.999","article-title":"Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group","volume":"136","author":"Reitamo","year":"2000","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.pop.2016.04.011_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MJT.0b013e31818a975c","article-title":"Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption","volume":"16","author":"Pariser","year":"2009","journal-title":"Am J Ther"},{"key":"10.1016\/j.pop.2016.04.011_bib28","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1046\/j.1365-2133.1998.02271.x","article-title":"Flucloxacillin in the treatment of atopic dermatitis","volume":"138","author":"Ewing","year":"1998","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.pop.2016.04.011_bib29","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1525-1470.2008.00768.x","article-title":"Methicillin-resistant Staphylococcus aureus colonization in children with atopic der-matitis","volume":"25","author":"Suh","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.pop.2016.04.011_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4370","article-title":"Systematic review of treatments for atopic eczema","volume":"4","author":"Hoare","year":"2000","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.pop.2016.04.011_bib31","first-page":"630","article-title":"Kwashiorkor in the United States: fad diets, perceived and true milk allergy, and nutritional ignorance","volume":"137","author":"Liu","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pop.2016.04.011_bib32","first-page":"117","article-title":"Long term follow-up in atopic dermatitis","volume":"114","author":"Rystedt","year":"1985","journal-title":"Acta Derm Venereol Suppl (Stockh)"},{"key":"10.1016\/j.pop.2016.04.011_bib33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-4362.1991.tb02641.x","article-title":"Prognosis of atopic dermatitis: a prospective study in early adulthood","volume":"30","author":"Lammintausta","year":"1991","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.pop.2016.04.011_bib34","series-title":"Atopic dermatitis: the epidemiology, causes, and prevention of atopic eczema","first-page":"41","article-title":"The natural history of atopic dermatitis","author":"Williams","year":"2000"},{"issue":"2","key":"10.1016\/j.pop.2016.04.011_bib35","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/bjd.12065","article-title":"Prevalence, incidence rates and persistence of contact allergy and allergic contact dermatitis in the odense adolescence cohort study: a 15-year follow-up","volume":"168","author":"Mortz","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.pop.2016.04.011_bib36","first-page":"249","article-title":"Diagnosis and Management of Contact Dermatitis","volume":"82","author":"Usatine","year":"2010","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.pop.2016.04.011_bib37","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJMcp1104084","article-title":"Hand Eczema","volume":"367","author":"Coenraads","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.pop.2016.04.011_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ad.2009.07.003","article-title":"Epidemiology of contact dermatitis: prevalence of sensitization to different allergens and associated factors","volume":"101","author":"Bordel-Gomez","year":"2010","journal-title":"Actas Dermosifiliogr"},{"issue":"3","key":"10.1016\/j.pop.2016.04.011_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1542\/pir.1-3-85","article-title":"Contact dermatitis","volume":"1","author":"Esterly","year":"1979","journal-title":"Pediatr Rev"},{"issue":"3 Suppl","key":"10.1016\/j.pop.2016.04.011_bib40","first-page":"S1","article-title":"Contact dermatitis: a practice parameter \u2013 update 2015","volume":"3","author":"Fonacier","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"year":"2009","series-title":"Color atlas of family medicine","author":"Usatine","key":"10.1016\/j.pop.2016.04.011_bib41"},{"issue":"9","key":"10.1016\/j.pop.2016.04.011_bib42","first-page":"1078","article-title":"Urticaria: evaluation and treatment","volume":"83","author":"Schaefer","year":"2011","journal-title":"Am Fam Physician"},{"issue":"6","key":"10.1016\/j.pop.2016.04.011_bib43","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1365-2133.2007.08283.x","article-title":"Guidelines for evaluation and management of urticarial in adults and children","volume":"157","author":"Grattan","year":"2007","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.pop.2016.04.011_bib44","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.pop.2016.04.011_bib45","first-page":"1123","article-title":"Urticaria and angioedema: a practial appropach","volume":"69","author":"Muller","year":"2004","journal-title":"Am Fam Physician"},{"issue":"6","key":"10.1016\/j.pop.2016.04.011_bib46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1542\/pir.34-6-247","article-title":"Anaphylaxis, urticaria, and angioedema","volume":"34","author":"Langley","year":"2013","journal-title":"Pediatr Rev"},{"issue":"3","key":"10.1016\/j.pop.2016.04.011_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008596.pub2","article-title":"Histamine H2-receptor antagonists for urticarial","author":"Fedorowicz","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.pop.2016.04.011_bib48","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","article-title":"The diagnosis and management of acute and chronic urticarial: 2014 update","volume":"133","author":"Bernstein","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.pop.2016.04.011_bib49","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2222.2007.02678.x","article-title":"British Society for Allergy and Clinical Immunology guidelines for the management of chronic urticarial and angioedema","volume":"37","author":"Powell","year":"2007","journal-title":"Clin Exp Allergy"},{"issue":"11","key":"10.1016\/j.pop.2016.04.011_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006137.pub2","article-title":"H1-antihistamines for chronic spontaneous urticaria","author":"Sharma","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.pop.2016.04.011_bib51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S1081-1206(10)63267-X","article-title":"Urticaria and angioedema: a clinical spectrum","volume":"76","author":"Charlesworth","year":"1996","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.pop.2016.04.011_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0889-8561(05)70051-5","article-title":"Evaluation of chronic eczema and urticarial and angioedema","volume":"19","author":"Kennedy","year":"1999","journal-title":"Immunol Allergy Clin N Am"},{"issue":"5","key":"10.1016\/j.pop.2016.04.011_bib53","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0196-0644(00)43749-2","article-title":"Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists","volume":"36","author":"Lin","year":"2000","journal-title":"Ann Emerg Med"},{"issue":"4","key":"10.1016\/j.pop.2016.04.011_bib54","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mai.2000.105706","article-title":"Chronic urticaria","volume":"105","author":"Greaves","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.pop.2016.04.011_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2500\/108854101778250562","article-title":"Chronic urticaria: mechanisms and treatment","volume":"22","author":"Fox","year":"2001","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"10.1016\/j.pop.2016.04.011_bib56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1081-1206(10)60462-0","article-title":"Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1","volume":"100","author":"Morgan","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.pop.2016.04.011_bib57","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0091-6749(98)70032-6","article-title":"Successful treatment of chronic urticarial with leukotriene antagonists","volume":"102","author":"Ellis","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.pop.2016.04.011_bib58","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0196-0644(95)70002-1","article-title":"Outpatient management of acute urticaria: the role of prednisone","volume":"26","author":"Pollack","year":"1995","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.pop.2016.04.011_bib59","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1067\/mjd.2002.122759","article-title":"Chronic urticaria","volume":"46","author":"Grattan","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2 suppl","key":"10.1016\/j.pop.2016.04.011_bib60","doi-asserted-by":"crossref","first-page":"S560","DOI":"10.1067\/mai.2003.78","article-title":"11. Allergic and immunologic diseases of the skin","volume":"111","author":"Blauvelt","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pop.2016.04.011_bib61","unstructured":"Novartis G. Xolair (omalizumab) [package insert]; 2010. Available at: http:\/\/www.gene.com\/patients\/medicines\/xolair."},{"issue":"6","key":"10.1016\/j.pop.2016.04.011_bib62","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2222.2009.03214.x","article-title":"Safety and tolerability of omalizumab","volume":"39","author":"Corren","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.pop.2016.04.011_bib63","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1081-1206(10)60360-2","article-title":"Effect of arterial hypertension on chronic urticaria duration","volume":"103","author":"Nebiolo","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pop.2016.04.011_bib64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1067\/mjd.2001.116217","article-title":"Natural course of physical and chronic urticaria and angioedema in 220 patients","volume":"45","author":"Kozel","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pop.2016.04.011_bib65","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1346-8138.2007.00276.x","article-title":"Chronic idiopathic urticaria: prevalence and clinical course","volume":"34","author":"Kulthanan","year":"2007","journal-title":"J\u00a0Dermatol"},{"issue":"3","key":"10.1016\/j.pop.2016.04.011_bib66","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaci.2004.02.049","article-title":"Chronic urticaria: pathogenesis and treatment","volume":"114","author":"Kaplan","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1 Suppl","key":"10.1016\/j.pop.2016.04.011_bib67","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.2500\/aap.2012.33.3554","article-title":"Urticaria and angioedema","volume":"33","author":"Carr","year":"2012","journal-title":"Allergy Asthma Proc"},{"issue":"10","key":"10.1016\/j.pop.2016.04.011_bib68","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMcp0803977","article-title":"Hereditary angioedema","volume":"359","author":"Zuraw","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.pop.2016.04.011_bib69","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/00128071-200203090-00002","article-title":"NSAID-induced urticaria and angioedema: a reappraisal of its clinical management","volume":"3","author":"Sanchez-Borges","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.pop.2016.04.011_bib70","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1081-1206(10)60594-7","article-title":"Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department","volume":"100","author":"Banerji","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.pop.2016.04.011_bib71","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jaad.2004.09.032","article-title":"Angioedema","volume":"53","author":"Kaplan","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pop.2016.04.011_bib72","first-page":"521","article-title":"The diagnosis and management of urticaria: a practice parameter. Part I: acute urticaria\/angioedema. Part II: chronic urticaria\/angioedema","volume":"85","author":"Joint Task Force on Practice Parameters","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pop.2016.04.011_bib73","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMcp011186","article-title":"Clinical practice: chronic urticaria and angioedema","volume":"346","author":"Kaplan","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2016.04.011_bib74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00128071-200102010-00005","article-title":"Treatment of urticaria. An evidence-based evaluation of antihistamines","volume":"2","author":"Lee","year":"2001","journal-title":"Am J Clin Dermatol"},{"issue":"3 Suppl 2","key":"10.1016\/j.pop.2016.04.011_bib75","first-page":"S1","article-title":"Food allergy: a practice parameter","volume":"96","author":"American College of Allergy, Asthma, & Immunology","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pop.2016.04.011_bib76","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJM199606203342503","article-title":"Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate","volume":"334","author":"Waytes","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2016.04.011_bib77","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1046\/j.1537-2995.1998.38698326333.x","article-title":"A\u00a0randomized, controlled trial to study the efficacy and safety of C1 inhibitor concentrate in treating hereditary angioedema","volume":"38","author":"Kunschak","year":"1998","journal-title":"Transfusion"},{"key":"10.1016\/j.pop.2016.04.011_bib78","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S1081-1206(10)60886-1","article-title":"Fresh frozen plasma for the treatment of hereditary angioedema","volume":"98","author":"Prematta","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pop.2016.04.011_bib79","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJM197204132861503","article-title":"Epsilon aminocaproic acid therapy of hereditary angioneurotic edema: a double-blind study","volume":"286","author":"Frank","year":"1972","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2016.04.011_bib80","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM197208312870907","article-title":"Tranexamic acid therapy in hereditary angioneurotic edema","volume":"287","author":"Sheffer","year":"1972","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pop.2016.04.011_bib81","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(99)00110-5","article-title":"Hepatocellular adenomas in patients taking danazol for hereditary angioedema","volume":"353","author":"Bork","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.pop.2016.04.011_bib82","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.molimm.2006.01.006","article-title":"Characterisation of a new C1 inhibitor mutant in a patient with hepatocellular carcinoma","volume":"43","author":"Monnier","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.pop.2016.04.011_bib83","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0091-6749(97)70095-2","article-title":"Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients","volume":"99","author":"Cicardi","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pop.2016.04.011_bib84","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1081-1206(10)60424-3","article-title":"Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients","volume":"100","author":"Bork","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.pop.2016.04.011_bib85","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","article-title":"Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond","volume":"114","author":"Agostoni","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pop.2016.04.011_bib86","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/10903120190940137","article-title":"Subcutaneous epinephrine in the prehospital setting","volume":"5","author":"Safdar","year":"2001","journal-title":"Prehosp Emerg Care"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454316300239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454316300239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:02:56Z","timestamp":1749063776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454316300239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0095454316300239"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2016.04.011","relation":{},"ISSN":["0095-4543"],"issn-type":[{"type":"print","value":"0095-4543"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allergic Dermatoses","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2016.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}